为探究综合膳食抗氧化指数（CDAI）与甲减风险的关系，菏泽市第三人民医院的研究人员基于美国国家健康与营养检查调查（NHANES）数据库展开研究，发现高 CDAI 与美国成年人低甲减风险相关，为预防甲减提供了饮食干预的理论依据。 在人体的 “健康大厦” 里 ...

The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adults with moderately to severely active Crohn disease (CD).

"If they are confirmed, it suggests to me that we need to modify the definition of LDA; that perhaps 6 to 9 [in CDAI score] is not satisfactory as a goal in rheumatoid arthritis," he said ...

The failure comes after Zeposia achieved clinical remission – defined as a CDAI score of less than 150 – in 39% of Crohn’s patients in the phase 2 STEPSTONE trial at 12 weeks, with 16% also ...

The goal of the Lupus Foundation of America's Collective Data Analysis Initiative (LFA CDAI) is to improve clinical trial design so new treatments can get to people who need them faster. The LFA CDAI ...

with a score ranging from 0 to 9.4. Secondary endpoints include the CDAI score, a composite assessment used to measure the severity of RA based on the sum of four assessment tools; the number of ...

Following completion of the Week 14 visit, rosnilimab-treated patients who achieved CDAI low disease activity (LDA) of ≤ 10, continued their assigned treatment through Week 28 in a blinded ...

The study achieved its primary endpoint in eliciting a mean change from baseline using the 28-Joint Disease Activity Score (DAS28-CRP ... disease activity index (CDAI) scale to achieve low ...